Bluepharma

Bluepharma, established in 2001, is a prominent pharmaceutical group specializing in the comprehensive development, production, and commercialization of medications across diverse therapeutic areas. With over two decades of innovation and a legacy spanning 50 years of industry experience, the company provides integrated support throughout the entire product lifecycle, from initial research and development to final market launch. Their operational model is designed to serve both patients and healthcare professionals, ensuring that all pharmaceutical solutions adhere to rigorous quality standards and meet specific client requirements.

The organization maintains a robust operational footprint with 500-1,000 employees dedicated to advancing medical science. Bluepharma operates from a single primary facility in Coimbra, Portugal, which serves as the hub for their manufacturing and strategic initiatives. A key component of their growth strategy is the ONConcept initiative, a specialized collaboration focused on oncology. This initiative includes a state-of-the-art industrial unit specifically engineered for the production of potent oral solid forms, demonstrating the company's technical capability in handling complex pharmaceutical manufacturing processes.

Bluepharma’s commitment to excellence is reflected in their multidisciplinary approach, which integrates scientific expertise with general management and operational efficiency. The company leverages a diverse workforce, including scientists, engineers, and IT professionals, to maintain its competitive edge in the B2B and B2C pharmaceutical markets. Meet Bluepharma's team to gain deeper insights into the leadership and organizational structure driving these advancements. By focusing on high-quality standards and strategic partnerships, Bluepharma continues to solidify its position as a key player in the European healthcare sector, consistently delivering innovative solutionsView more...